A detailed history of Goal Vest Advisory LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Goal Vest Advisory LLC holds 13,572 shares of ABBV stock, worth $2.44 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
13,572
Previous 13,860 2.08%
Holding current value
$2.44 Million
Previous $2.38 Million 12.75%
% of portfolio
0.81%
Previous 0.77%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$163.84 - $199.33 $47,185 - $57,407
-288 Reduced 2.08%
13,572 $2.68 Million
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $154,325 - $180,217
-997 Reduced 6.71%
13,860 $2.38 Million
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $1.3 Million - $1.49 Million
8,160 Added 121.85%
14,857 $2.71 Million
Q4 2023

Jan 02, 2024

BUY
$137.6 - $154.97 $806,060 - $907,814
5,858 Added 698.21%
6,697 $1.04 Million
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $935 - $1,082
7 Added 0.84%
839 $125,000
Q2 2023

Jul 17, 2023

SELL
$132.51 - $164.9 $6,625 - $8,245
-50 Reduced 5.67%
832 $112,000
Q1 2023

Apr 03, 2023

BUY
$144.61 - $166.54 $13,014 - $14,988
90 Added 11.36%
882 $140,000
Q4 2022

Jan 06, 2023

BUY
$138.31 - $165.87 $6,915 - $8,293
50 Added 6.74%
792 $0
Q3 2022

Oct 11, 2022

SELL
$134.21 - $153.93 $42,544 - $48,795
-317 Reduced 29.93%
742 $100,000
Q2 2022

Jul 06, 2022

BUY
$137.62 - $174.96 $117,527 - $149,415
854 Added 416.59%
1,059 $163,000
Q1 2022

May 03, 2022

SELL
$131.98 - $163.75 $299,858 - $372,040
-2,272 Reduced 91.72%
205 $33,000
Q2 2021

Sep 01, 2021

SELL
$105.21 - $117.21 $345,614 - $385,034
-3,285 Reduced 57.01%
2,477 $279,000
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $13,401 - $14,753
131 Added 2.33%
5,762 $624,000
Q4 2020

Jan 28, 2021

BUY
$80.49 - $108.67 $453,239 - $611,920
5,631 New
5,631 $603,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Goal Vest Advisory LLC Portfolio

Follow Goal Vest Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goal Vest Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Goal Vest Advisory LLC with notifications on news.